321
Participants
Start Date
July 31, 2011
Primary Completion Date
May 31, 2013
Study Completion Date
June 30, 2014
GTx-024
subjects will be randomized to receive GTx-024 for the full duration of the trial.
placebo
subject will receive placebo for the duration of the trial
GTx Investigative Site, Rochester
GTx Investigative Site, Lancaster
GTx Investigative Site, Winston-Salem
GTx Investigative Site, Burlington
GTx Investigative Site, Wilmington
GTx Investigative Site, Flat Rock
GTx Investigative Site, Spartanburg
GTx Investigative Site, Orange City
GTx Investigative Site, Miami
GTx Investigative Site, Aventura
GTx Investigative Site, Tampa
GTx Investigative Site, Birmingham
GTx Investigative Site, Tupelo
GTx Investigative Site, Ashland
GTx Investigative Site, Canfield
Gabrail Cancer Center, Canton
GTx Investigative Site, Sandusky
GTx Investigative Site, Indianapolis
GTx Investigative Site, Saint Clair Shores
GTx Investigative Site, Great Falls
GTx Investigative Site, Skokie
GTx Investigative Site, Peoria
GTx Investigative Site, Decatur
GTx Investigative Site, Round Rock
GTx Investigative Site, Long Beach
GTx Investigative Site, Portland
GTx Investigative Site, Concord
Lead Sponsor
GTx
INDUSTRY